Balance Sheet Details

6 Months Ended

Jun. 30, 2024

5. BALANCE SHEET DETAILS

Prepaid expenses and other current assets consisted of the following (in thousands):


	June 30, 2024		December 31, 2023
Prepaid clinical costs	$	1,655	$	2,574
Prepaid research and development costs		905		1,238
Australian tax incentive receivable		290		747
Prepaid insurance		334		857
Prepaid subscriptions		2,317		1,130
Interest receivable		3,483		3,051
Due from Radionetics (Note 11)		119		90
Landlord improvements receivable		890		5,210
Receivable for common stock issued		318		253
Other		1,512		448
Total	$	11,823	$	15,598

Property and equipment, net consisted of the following (in thousands):


	June 30, 2024			December 31, 2023
Leasehold improvements	$	11,000		$	9,837
Lab equipment		5,318			4,253
Office equipment		2,100			1,854
Computers and software		60			5
Property and equipment at cost		18,478			15,949
Less accumulated depreciation and amortization		(6,231	)		(5,068	)
Total	$	12,247		$	10,881

Accounts payable and accrued expenses consisted of the following (in thousands):


	June 30, 2024		December 31, 2023
Accounts payable	$	8,872	$	6,548
Accrued clinical trial costs		4,373		5,527
Accrued research and development costs		4,527		2,312
Accrued outside services and professional fees		5,125		1,726
Accrued landlord improvements		19		3,816
Other accrued expenses		1,081		3,267
Total	$	23,997	$	23,196